Understanding the Cd47 Gene: Insights for Researchers and Enthusiasts

Discover the revolutionary Cd47 Gene Expression Kit developed by Alpha Lifetech Incorporation, the leading biotechnology company in the field of genetic research and innovation. Our advanced kit allows researchers and scientists to analyze and quantify CD47 gene expression with unmatched precision and accuracy, The CD47 gene has been the subject of extensive research in recent years due to its significant role in immune regulation and cancer progression. With our innovative kit, researchers can gain a comprehensive understanding of CD47 gene expression and its potential implications in various disease states, including cancer, autoimmune disorders, and neurological conditions, Designed with cutting-edge technology and rigorous quality control, the CD47 Gene Expression Kit offers a streamlined and efficient workflow for gene expression analysis. Whether you are conducting basic research, drug discovery, or clinical diagnostics, our kit provides reliable and reproducible results, empowering you to make groundbreaking discoveries and advancements in the field of genetic research, Join the forefront of genetic innovation and unlock the potential of the CD47 gene with Alpha Lifetech's CD47 Gene Expression Kit

Hot Selling Product

ALP64649-Recombinant Human CD47/MER6 Protein, Fc Tag

ALP64587-Recombinant Mouse CD47/MER6 Protein, His Tag

ADT1354-Letaplimab Biosimilar-(CD47)-Research Biosimilar Antibody

ADT1361-Ligufalimab Biosimilar-(CD47)-Research Biosimilar Antibody

ADT1705-Volagidemab Biosimilar-(GCGR)-Research Biosimilar Antibody

ADT1033-Anetumab Biosimilar-Anti-MSLN mAb-Research Grade

Expert Tips For Cd47 Gene Market Leader Factory-Direct Excellence

In the rapidly evolving field of biotechnology, sourcing high-quality reagents is crucial for success. At Alpha Lifetech Inc., we are proud to be a market leader in the production of CD47 gene-related products, positioning ourselves as a direct factory supplier committed to excellence. Our foundation is built on the extensive expertise of our scientific team in membrane Protein production, nanobody discovery, and monoclonal antibody development. With nearly 10,000 high-quality reagents and drug target antibodies in our catalog, we cater to the diverse needs of global buyers seeking reliable and effective solutions. Our commitment to excellence is not just in our products but also in our processes. By leveraging cutting-edge technology and maintaining stringent quality control measures, we ensure that every batch of our CD47 reagents meets the highest industry standards. Buyers can trust that our factory-direct offerings provide cost-effective solutions without compromising quality. As the demand for CD47-related research grows, Alpha Lifetech Inc. is here to support researchers and organizations globally, providing them with unparalleled access to resources crucial for groundbreaking studies in cancer therapy and immunology. Choosing Alpha Lifetech Inc. means partnering with a trusted name in the biotech industry. Our dedication to innovation and customer satisfaction empowers researchers to achieve their goals with confidence. We invite global purchasers to explore our extensive catalog and experience firsthand the excellence of Alpha Lifetech—where your scientific advancements begin with superior quality.

Expert Tips For Cd47 Gene Market Leader Factory-Direct Excellence

Dimension	Data Point
Market Size (2023)	$1.5 Billion
Growth Rate (CAGR 2023-2030)	8%
Key Applications	Cancer Therapy, Immune Modulation
Top Regions	North America, Europe, Asia-Pacific
Leading Research Institutes	Institute A, Institute B, Institute C
Key Trends	Personalized Medicine, Combination Therapies
Regulatory Landscape	FDA Approvals and Guidelines

CD47 Gene Expression Levels in Different Tissue Types

The CD47 gene, known for its role in immune evasion and cellular signaling, exhibits varying levels of expression across different tissue types. Understanding these variations is crucial for its potential applications in therapeutic strategies, particularly in cancer treatment where CD47's overexpression can inhibit phagocytosis by immune cells. In this analysis, we present a bar chart showing the relative expression levels of CD47 in five key tissues: Heart, Liver, Lung, Kidney, and Brain. The data indicates that CD47 expression is highest in the Liver, suggesting a significant role in hepatic functions or responses to systemic inflammation. Conversely, the Heart and Brain also show notable expression levels, potentially reflecting their unique immunological and physiological environments. These findings emphasize the importance of tissue context when considering CD47 as a target for therapeutic intervention, as its varying expression can influence both efficacy and safety profiles in clinical settings. Further research is warranted to explore the functional implications of these expression patterns in health and disease.